Kathmere Capital Management’s CVS Health CVS Stock Holding History

Kathmere Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$512K	Sell	4,947 -6	-0.1%	-$536	0.03%	394
2026 Q1	$356K	Sell	4,953 -1,931	-28%	-$149K	0.02%	428
2025 Q4	$546K	Buy	6,884 +2,153	+46%	+$170K	0.04%	301
2025 Q3	$357K	Buy	4,731 +1,712	+57%	+$117K	0.03%	352
2025 Q2	$208K	Sell	3,019 -948	-24%	-$62.2K	0.02%	449
2025 Q1	$269K	Buy	+3,967	New	+$237K	0.02%	350
2023 Q1	–	Sell	-2,628	Closed	-$245K	–	233
2022 Q4	$245K	Buy	+2,628	New	+$254K	0.04%	164
2021 Q1	–	Sell	-300	Closed	-$20K	–	195
2020 Q4	$20K	Buy	+300	New	+$19.5K	﹤0.01%	285

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Kathmere Capital Management's CVS Position: Q2 2026 in Review

Kathmere Capital Management reduced its CVS Health (CVS) stake by 0.12% in Q2 2026, selling an estimated $536 and leaving 4,947 shares worth $512K. The position accounts for 0.03% of the portfolio, ranked #394.

Kathmere Capital Management first reported a position in CVS in Q4 2020 and has held it in 8 quarters since. The position peaked at $546K in Q4 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Kathmere Capital Management held 4,947 shares of CVS Health worth $512K as of Q2 2026.
Kathmere Capital Management sold 6 CVS Health shares in Q2 2026, an estimated $536.
CVS Health made up 0.03% of Kathmere Capital Management's portfolio in Q2 2026, its #394 holding.
Kathmere Capital Management first reported a position in CVS Health in Q4 2020 and has held it in 8 quarters since.
Kathmere Capital Management's CVS Health position peaked at $546K in Q4 2025.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Kathmere Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.